UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 26, 2022

Accession Number:	0001140361-22-011417
Submission Type:	POS AM
CIK: 0001797768 Company Name: Kinnate Biopharma Inc. File Number: 333-261970